259 related articles for article (PubMed ID: 17512352)
1. The management of recurrent ovarian cancer.
Bukowski RM; Ozols RF; Markman M
Semin Oncol; 2007 Apr; 34(2 Suppl 2):S1-15. PubMed ID: 17512352
[No Abstract] [Full Text] [Related]
2. Ovarian cancer: a focus on management of recurrent disease.
Herzog TJ; Pothuri B
Nat Clin Pract Oncol; 2006 Nov; 3(11):604-11. PubMed ID: 17080178
[TBL] [Abstract][Full Text] [Related]
3. [Decision-making of treatment and relative problems about recurrent and drug-resistant gynecologic neoplasms].
Xie X; Cheng XD
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):801-3. PubMed ID: 21211274
[No Abstract] [Full Text] [Related]
4. [Therapy for ovarian cancer--general review].
Ochiai K
Nihon Rinsho; 2004 Oct; 62 Suppl 10():517-21. PubMed ID: 15535299
[No Abstract] [Full Text] [Related]
5. New developments in the management of ovarian cancer.
Hoskins WJ
J Med Assoc Ga; 2003; 92(1):23-6, 33. PubMed ID: 12743902
[No Abstract] [Full Text] [Related]
6. Ovarian cancer.
Bapsy PP
J Indian Med Assoc; 2012 Dec; 110(12):894-7. PubMed ID: 23936953
[No Abstract] [Full Text] [Related]
7. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer: strategies for overcoming resistance to chemotherapy.
Agarwal R; Kaye SB
Nat Rev Cancer; 2003 Jul; 3(7):502-16. PubMed ID: 12835670
[TBL] [Abstract][Full Text] [Related]
9. Cancer ovary, present and future of management.
Parvez T
J Ayub Med Coll Abbottabad; 2003; 15(2):65-8. PubMed ID: 14552255
[TBL] [Abstract][Full Text] [Related]
10. Modern management of recurrent ovarian carcinoma. A systematic approach to a chronic disease.
Michener CM; Belinson JL
Oncology (Williston Park); 2005 Sep; 19(10):1277-85; discussion 1285, 1288, 1293. PubMed ID: 16285224
[TBL] [Abstract][Full Text] [Related]
11. Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer.
Vergote I; Amant F
Gynecol Oncol; 2006 Sep; 102(3):415-7. PubMed ID: 16979430
[No Abstract] [Full Text] [Related]
12. [Ovarian cancer].
Langmár Z; Csömör S; Németh M; Tomcsik Z; Joó JG
Orv Hetil; 2011 Dec; 152(49):1977-84. PubMed ID: 22106167
[No Abstract] [Full Text] [Related]
13. Intraperitoneal chemotherapy and intraperitoneal washing cytology in management of ovarian cancer.
Fujiwara K
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():354-8. PubMed ID: 10895180
[No Abstract] [Full Text] [Related]
14. Challenges of IP chemotherapy for ovarian cancer.
Anselmo-Murphy AM
Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):21-2. PubMed ID: 19856604
[No Abstract] [Full Text] [Related]
15. [Therapeutic concept in ovarian cancer].
Rath W; Meden H
Med Klin (Munich); 1991 May; 86(5):263-8. PubMed ID: 1875867
[No Abstract] [Full Text] [Related]
16. Novel therapies for recurrent ovarian cancer management.
Bhoola SM; Alvarez RD
Expert Rev Anticancer Ther; 2004 Jun; 4(3):437-48. PubMed ID: 15161442
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal antineoplastic agents in the management of ovarian cancer.
Tropé C; Kaern J; Vergote I
Eur J Surg Suppl; 1991 May; (561):83-6. PubMed ID: 1720054
[No Abstract] [Full Text] [Related]
18. [Ovarian carcinoma: various aspects of intraperitoneal chemotherapy].
Los G; Beijnen JH; Dubbelman R; ten Bokkel Huinink WW; McVie JG
Ned Tijdschr Geneeskd; 1988 Jul; 132(29):1347-50. PubMed ID: 3412503
[No Abstract] [Full Text] [Related]
19. Improving outcomes in ovarian cancer.
Vaughan M; Sykes P; Johnson C; Fitzharris B;
N Z Med J; 2006 Sep; 119(1242):U2171. PubMed ID: 16998572
[No Abstract] [Full Text] [Related]
20. [Remote results of the standard ovary cancer treatment].
Ushakov II; Mel'ko AI; Kira EF; Ermolinskiĭ II
Voen Med Zh; 2005 Nov; 326(11):36-8. PubMed ID: 16404905
[No Abstract] [Full Text] [Related]
[Next] [New Search]
